2018 FDA Tides Harvest

Pharmaceuticals

Danah Al Shaer¹  BeatrizG. de la Torre¹  Othman Al Musaimi¹  Fernando Albericio² 

[1] KRISP, School of Laboratory of Medicine and Medical Science, College of Health Sciences, University of KwaZulu-Natal, Durban 4001, South Africa;School of Chemistry and Physics, University of KwaZulu-Natal, Durban 4001, South Africa;

关键词: dotatate;    drugs;    inotersen;    Lutathera;    oligonucleotides;    Onpattro;    patisiran;    peptides;    pharmaceutical market;    Tegsedi;   

DOI  :  10.3390/ph12020052

来源: DOAJ

【 摘 要 】

In 2018, the United States Food and Drug Administration (FDA) approved a total of 59 new drugs, three of them (5%) are TIDES (or also, -tides), two oligonucleotides and one peptide. Herein, the three TIDES approved are analyzed in terms of medical target, mode of action, chemical structure, and economics.

【 授权许可】

Unknown